BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1656741)

  • 1. Azithromycin compared with cephalexin in the treatment of skin and skin structure infections.
    Mallory SB
    Am J Med; 1991 Sep; 91(3A):36S-39S. PubMed ID: 1656741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, double-dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infections.
    Kiani R
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):880-4. PubMed ID: 1662638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues. European Azithromycin Study Group.
    Daniel R
    J Int Med Res; 1991; 19(6):433-45. PubMed ID: 1663466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cephalexin in the treatment of skin and soft-tissue infections.
    Derrick CW; Reilly K
    Postgrad Med J; 1983; 59 Suppl 5():43-6. PubMed ID: 6364089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of azithromycin versus clarithromycin in the treatment of patients with upper respiratory tract infections.
    Müller O
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():137-46. PubMed ID: 8396085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections.
    Rodriguez-Solares A; Pérez-Gutiérrez F; Prosperi J; Milgram E; Martin A
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():103-9. PubMed ID: 8396081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections.
    Dark D
    Am J Med; 1991 Sep; 91(3A):31S-35S. PubMed ID: 1656740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial.
    Parish LC; Jorizzo JL; Breton JJ; Hirman JW; Scangarella NE; Shawar RM; White SM;
    J Am Acad Dermatol; 2006 Dec; 55(6):1003-13. PubMed ID: 17097398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of staphylococcal skin infections: a comparison of cephalexin and dicloxacillin.
    Dillon HC
    J Am Acad Dermatol; 1983 Feb; 8(2):177-81. PubMed ID: 6826814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical comparison of cefuroxime axetil, cephalexin and cefadroxil in the treatment of patients with primary infections of the skin or skin structures.
    Gooch WM; Kaminester L; Cole GW; Binder R; Morman MR; Swinehart JM; Wisniewski M; Yilmaz HM; Collins JJ
    Dermatologica; 1991; 183(1):36-43. PubMed ID: 1769413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily azithromycin in the treatment of adult skin and skin-structure infections.
    Amaya-Tapia G; Aguirre-Avalos G; Andrade-Villanueva J; Peredo-González G; Morfín-Otero R; Esparza-Ahumada S; Rodríguez-Noriega E
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():129-35. PubMed ID: 8396084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies of azithromycin in skin and soft-tissue infections and sexually transmitted infections by Neisseria and Chlamydia species.
    Lassus A
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():115-21. PubMed ID: 2154430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of use of cefdinir versus cephalexin for treatment of skin infections in pediatric patients. The Cefdinir Pediatric Skin Infection Study Group.
    Tack KJ; Keyserling CH; McCarty J; Hedrick JA
    Antimicrob Agents Chemother; 1997 Apr; 41(4):739-42. PubMed ID: 9087480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azithromycin and amoxicillin in the treatment of acute maxillary sinusitis.
    Casiano RR
    Am J Med; 1991 Sep; 91(3A):27S-30S. PubMed ID: 1656739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
    Giordano PA; Elston D; Akinlade BK; Weber K; Notario GF; Busman TA; Cifaldi M; Nilius AM
    Curr Med Res Opin; 2006 Dec; 22(12):2419-28. PubMed ID: 17257456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefdinir versus cephalexin for the treatment of skin and skin-structure infections. The Cefdinir Adult Skin Infection Study Group.
    Tack KJ; Littlejohn TW; Mailloux G; Wolf MM; Keyserling CH
    Clin Ther; 1998; 20(2):244-56. PubMed ID: 9589816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind comparison of cephradine and cephalexin in the treatment of skin and soft-tissue infections due to Staphylococcus aureus.
    Hubsher JA; Gadebusch HH; Itkin AG
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):579-88. PubMed ID: 819217
    [No Abstract]   [Full Text] [Related]  

  • 18. Cefaclor in the management of common bacterial skin diseases.
    Finnerty EF; Folan DW
    Cutis; 1979 Sep; 24(3):304-6. PubMed ID: 477398
    [No Abstract]   [Full Text] [Related]  

  • 19. Ofloxacin versus cephalexin in the treatment of skin, skin structure, and soft-tissue infections in adults.
    Powers RD; Schwartz R; Snow RM; Yarbrough DR
    Clin Ther; 1991; 13(6):727-36. PubMed ID: 1790547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxifloxacin versus cephalexin in the treatment of uncomplicated skin infections.
    Parish LC; Routh HB; Miskin B; Fidelholtz J; Werschler P; Heyd A; Haverstock D; Church D
    Int J Clin Pract; 2000 Oct; 54(8):497-503. PubMed ID: 11198726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.